UBS AM’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-278
| Closed | -$95.8K | – | 2903 |
|
2019
Q3 | $95.8K | Buy |
278
+26
| +10% | +$8.96K | ﹤0.01% | 2668 |
|
2019
Q2 | $232K | Buy |
252
+13
| +5% | +$12K | ﹤0.01% | 2497 |
|
2019
Q1 | $381K | Buy |
239
+15
| +7% | +$23.9K | ﹤0.01% | 2216 |
|
2018
Q4 | $418K | Hold |
224
| – | – | ﹤0.01% | 2065 |
|
2018
Q3 | $528K | Sell |
224
-47
| -17% | -$111K | ﹤0.01% | 2068 |
|
2018
Q2 | $934K | Buy |
271
+57
| +27% | +$196K | ﹤0.01% | 1834 |
|
2018
Q1 | $607K | Buy |
214
+21
| +11% | +$59.5K | ﹤0.01% | 1950 |
|
2017
Q4 | $497K | Buy |
193
+17
| +10% | +$43.8K | ﹤0.01% | 1976 |
|
2017
Q3 | $498K | Buy |
+176
| New | +$498K | ﹤0.01% | 1948 |
|
2017
Q1 | – | Sell |
-1
| Closed | -$1K | – | 2500 |
|
2016
Q4 | $1K | Sell |
1
-188
| -99% | -$188K | ﹤0.01% | 2485 |
|
2016
Q3 | $474K | Hold |
189
| – | – | ﹤0.01% | 2011 |
|
2016
Q2 | $579K | Sell |
189
-815
| -81% | -$2.5M | ﹤0.01% | 1888 |
|
2016
Q1 | $3.19M | Sell |
1,004
-133
| -12% | -$422K | ﹤0.01% | 1171 |
|
2015
Q4 | $5.84M | Sell |
1,137
-15,492
| -93% | -$79.5M | 0.01% | 1017 |
|
2015
Q3 | $52.9M | Sell |
16,629
-14,463
| -47% | -$46M | 0.06% | 350 |
|
2015
Q2 | $124M | Buy |
31,092
+7,032
| +29% | +$28.1M | 0.12% | 193 |
|
2015
Q1 | $96.1M | Sell |
24,060
-2,381
| -9% | -$9.51M | 0.09% | 248 |
|
2014
Q4 | $130M | Sell |
26,441
-458
| -2% | -$2.25M | 0.12% | 188 |
|
2014
Q3 | $109M | Buy |
26,899
+2,253
| +9% | +$9.16M | 0.11% | 207 |
|
2014
Q2 | $99.7M | Buy |
24,646
+2,448
| +11% | +$9.9M | 0.1% | 240 |
|
2014
Q1 | $101M | Sell |
22,198
-3
| -0% | -$13.6K | 0.11% | 216 |
|
2013
Q4 | $77.8M | Buy |
22,201
+1,539
| +7% | +$5.39M | 0.09% | 250 |
|
2013
Q3 | $85M | Buy |
20,662
+125
| +0.6% | +$514K | 0.11% | 220 |
|
2013
Q2 | $81.3M | Buy |
+20,537
| New | +$81.3M | 0.1% | 226 |
|